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Introduction
New psychoactive substances (NPS) are drugs that are chemically altered relatives of known controlled drugs. From a European perspective, the definition of NPS includes substances that are not listed in any of the schedules to the 1961 United Nations Single Convention on Narcotic Drugs as well as the 1971 United Nations Convention on Psychotropic Substances and which may pose a comparable threat to public health as the substances listed in these schedules. [1, 2] As many of these compounds are not yet listed, they are euphemistically advertised as "legal highs", "bath salts" or "research chemicals" in many countries.
Distribution and supply of NPS is mostly facilitated through online shops and high street retailers and their availability has increased drastically in recent years, with a sevenfold increase in reported seizures in the EU between 2008 and 2013. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), through the EU Early Warning System, is currently monitoring more than 560 substances. [3] In 2015 alone, the EU early warning system reported 98 new compounds with synthetic ring substituted cathinones, synthetic cannabinoids and phenylethylamines representing the major contributions. [4, 5] Seizures of the Central Customs Authority in Germany are in accordance with these numbers, with cathinones (42 %), cannabinoids (38 %) and phenethylamines (17 %) accounting for the majority of all NPS cases dealt with in the years 2012-2015. Strikingly, these data reflect the general trend in an ever faster developing drug market: While in 2012 a total of 13 different (at that time) legal NPS were registered in our laboratories, this number doubled to 26 in 2015 and is likely to further increase in 2016 ( Figure 1 ).
As a relatively new class of phenethylamines, a number of phenidate derivatives are available on the NPS drug market. Phenidates are chemical analogs of methylphenidate (1) which is well known as the prescription drug Ritalin ® . Methylphenidate is clinically used in the treatment of attention deficit hyperactivity disorder (ADHD). It acts as a reuptake inhibitor at the dopamine transporter (DAT) (K i = 640 nM for (-)-cocaine and 390 nM for D-threo-methylphenidate), and also acts as a blocker of norepinephrine uptake. However, unlike cocaine, nearly no activity at the serotonin transporter (SERT) was reported. [6] [7] [8] Methylphenidate increases central nervous system activity and effects at lower doses include improved cognition, heightened alertness and reduced fatigue whereas higher doses can induce euphoria. [9] [10] [11] [12] On these grounds methylphenidate has been abused as a recreational drug since the 1960s and more recently as a "neuroenhancing" "smart drug". [12, 13] Possible side effects related to methylphenidate overdoses include tachycardia, hallucinations and psychosis. [11, 13] Since methylphenidate is a widely regulated pharmaceutical, structurally diverse and often more potent NPS of the phenidate class have entered the drug market. [14, 15] Molecular structures and the respective activities at the DAT have been reported for many of these compounds in the scientific literature, thus making the targeted synthesis of potent phenidate analogs for the drug market likely. [16] Phenidates were also recently seized by German authorities, such as 4-methylmethylphenidate (2), 3,4-dichloromethylphenidate (3), ethylphenidate (4), 3,4-dichloroethylphenidate (5) , and N-benzyl-ethylphenidate (7) , while the related ethylnaphthidate (6) is sold online in the United Kingdom ( Figure 2 ). Little is known about the pharmacology and hazards of phenidate analogs despite their structural similarity. [11, 12, [16] [17] [18] However, ethylphenidate (4) has been linked to a number of deaths [19] [20] [21] [22] [23] and concerns have been expressed about ethylphenidate injection in drug users. [21, 22] It has also been long recognized that ethylphenidate is formed in vivo following co-administration of methylphenidate with alcohol. [25, 26] The reaction of governments in the European Union to the challenge posed by NPS can be broadly differentiated into three legal response types. These may consist of a) the application of existing laws designed for consumer-or health-protection and pharmaceutical legislation; b) amending of drug laws by e. g. introducing group definitions of controlled substances; c) innovative approaches that e. g. define a substance by its psychoactive effect rather than its chemical structure. [27] Procedure a) can be difficult to implement and pharmaceutical legislation in e.g. Germany is not applicable to "substances that […] are only consumed to intoxicate while being detrimental to health" according to a recent ruling by the European Court of Justice (ECJ). [28] Thus, Germany has recently introduced chemical group definitions b) like other countries in the EU. The corresponding new law defines new psychoactive substances as substances that are covered by the chemical compound groups defined in the annex to that law. [29] Authorities and forensic chemists need to reliably elucidate the type of NPS in question.
While this is feasible by combining routine analytical methods provided that the NPS are listed in existing databases, difficulties arise when a NPS is not well documented or unknown. To assist efforts in the reliable structural elucidation of NPS, this study presents an extensive characterization of newly emerging phenidate analogs 2-7.
Experimental

Chemicals
Chemicals were purchased from Sigma-Aldrich (Steinheim, Germany) and used as purchased without further purification. CDCl 3 and D 2 O were obtained from Sigma-Aldrich (Steinheim, Germany) and Deutero GmbH (Kastellaun, Germany). All solvents and reagents used were of analytical grade. Phenidates 2, 3, 4, 5 and 7 were parts of confiscations by German authorities whereas naphthidate 6 was obtained from a test purchase.
Sample preparation
For the analysis of the compounds 2 to 7 by gas chromatography mass spectrometry (GC-MS) approximately 1 mg of the salts were dissolved in 1 mL ethanol. For the analysis of the and 6 had to be recrystallized from MeOH/EtOAc.
Gas chromatography mass spectrometry (GC-MS) (routine method of analysis)
Electron ionization (EI) mass spectra were obtained from a DSQ II quadrupole mass spectrometer (Thermo Scientific, Dreieich, Germany) coupled to a gas chromatograph (Focus GC, Thermo Scientific, Dreieich, Germany) with an auto sampler AS 3000 (Thermo Scientific, Dreieich, Germany). Samples (1 µL) were introduced via the gas chromatograph with split injection 1:100 using a fused silica capillary column Zebron 2B-5 (30 m × 0.25 mm, film thickness 0.25 µm) (Phenomenex, Aschaffenburg, Germany). The temperature program started with an initial temperature of 50 °C, held for 2 min, followed by a ramp to 240 °C with 16°C/min and held for 1 min. The final temperature was 300 °C using a 30 °C/min temperature ramp and held for 5 min, thus resulting in a total run time of 22 min. The injector temperature was 260 °C. The transfer line temperature was maintained at 280 °C.
The carrier gas (helium) was set at a constant flow rate of 1.8 mL/min. The electron ionization (EI) energy was 70 eV with an emission current of 100 µA. The scan time was 0.36 s and the scan range was m/z 40-550. The ion source temperature was maintained at 250 °C.
GC-MS (modified protocol)
Chromatograms and EI mass spectra were obtained with a GCMS-QP2010SE GC-MS (Shimadzu, Duisburg, Germany) with a GC 2010 plus auto sampler (Shimadzu, Duisburg, Germany). Samples (0.5 µL) were introduced via the gas chromatograph with split injection 1:100. For separation, a fused silica capillary column Optima-1 MS Accent (30 m × 0.25 mm, film thickness 0.25 µm) (Macherey-Nagel, Düren, Germany) was employed. The temperature program started with an initial temperature of 50 °C, held for 2 min, followed by a ramp to 230 °C with 7 °C/min, and held for 2 min. The final temperature was 300 °C, reached with 35 °C/min and held for 5 min, thus resulting in a total run time of 36 min. The injector temperature was 260 °C. The transfer line temperature was maintained at 280 °C. The carrier gas was helium in constant flow mode at a flow rate of 1.8 mL/min. The electron ionization (EI) energy was 70 eV with an emission current of 100 µA. The scan time was 0.36 s and the scan range was m/z 40-550. The ion source temperature was maintained at 250 °C.
Quadrupole time-of-flight electrospray ionization tandem mass spectrometry (QTOF-ESI-
MS/MS)
The employed mass spectrometer was a Bruker micrOTOF-Q III (Bruker, Bremen, Germany) coupled with an electrospray ionization source operated in positive ion mode. Sodium formate was used as calibration standard and Bruker DataAnalysis 4.2 SR1 Workstation Software was used for data analysis. Samples were introduced via continuous direct infusion with a syringe-pump set to 180 µL/h and a drying gas flow of 4 L N 2 /min. Drying gas temperature was set to 180 °C, nebulizer pressure to 0.3 bar and capillary voltage to 2500 V.
Flow injection analysis (FIA) was employed to optimize the collision energy (CE) for each multiple reaction monitoring (MRM) transition.
Nuclear magnetic resonance spectroscopy (NMR)
NMR spectra for compounds 2-6 were recorded using a Bruker UltraShield (7.05 Tesla, 300 MHz) Fourier 300 spectrometer (Bruker, Coventry, UK) equipped with a dual 1 H/ 13 C probe (5 mm) with 2H lock and fitted with a z gradient coil at 298 K. The NMR spectrum for compound 7 was recorded at the NMR spectrometry facility of the Institute for Organic Chemistry of the University of Cologne. The one-and two-dimensional NMR measurements ( 1 H-NMR, 13 C-DEPT, 1 H/ 1 H-COSY, 1 H/ 13 C-HSQC, 1 
H/ 13 C-HMBC and 1 H/ 1 H-NOESY)
were performed with a Bruker Avance II+ 600 NMR spectrometer (resonance frequency for 1 H 600.20 MHz) with a H,P,X TBI z-Grad probe at 298 K and internal chemical shift references were based on residual solvent peaks. Suggested assignments were aided by 1-D and 2-D experiments and internal chemical shift references were based on residual solvent peaks.
Infrared spectroscopy (IR)
The spectrometer used was a Bruker Alpha FT-IR (Bruker, Ettlingen, Germany) equipped with a diamond platinum ATR crystal. The wavelength resolution was set to 4 cm -1 . IR spectra were collected in a range of 400-4000 cm -1 with 20 scans per spectrum.
X-ray diffraction
The diffractometer employed was a Bruker D8 Venture with Kappa-goniometer and a Cu-Microfocus X-ray source (Bruker, Karlsruhe, Germany). Crystallographic data have been deposited with the Cambridge Crystallographic Data center. These data can be obtained online free of charge from the Cambridge Crystallographic Data Centre (CCDC). [30] CCDC 1520751 (2), CCDC 1520753 (3), CCDC 1520750 (4), CCDC 1520752 (5), CCDC 1520755 (6) and CCDC 1520749 (7) contain the supplementary crystallographic data for this compound.
Computational details
All theoretical calculations were performed with the program package TURBOMOLE-7.0.2 and density functional theory (DFT). [31] The employed density functional was the GGA BP86-functional developed by Becke and Perdew, combined with the contracted def2-SVP or def2-TZVP basis sets by Ahlrich et al. [32, 33] as specified. On transition states, subsequent single point calculations employing the B3LYP-functional were conducted. [34] For some This article is protected by copyright. All rights reserved.
calculations the dispersion correction DFT-D3(BJ) was used as specified. [35, 36] The multipole accelerated resolution of identity approximation for two electron integral evaluation was used. All stationary points were fully optimized and confirmed by separate analytical frequency calculations. Transition structures were optimized with quasi-Newton-Raphson methods by using the Powell update algorithm for hessian matrix approximation (subsequent analytical frequency calculation). Absolute energies were zero-point corrected with the vibrational information received from harmonic analytical frequency calculations.
Coordinates of transition structures and stationary points can be found within the Supporting Information.
Results and discussion
X-ray diffraction
Crystal structure analysis revealed that all six phenidate analogs were hydrochloride salts.
Crystal structures of 2 and 3 have been previously published by Deutsch et al. and are in agreement with our own measurements. [37] The crystal structures of the phenidate analogs, depicted as the (R,R)-enantiomers, are shown in Figure 3 , although all measured crystals consisted of racemic material as evident from their point groups. The defining dihedral angles and distances for all compounds are summarized in Table 1 . For all measured samples the Similar to the crystal structures of 3, 4, 5 and 6, the carbonyl oxygen is rotated to closer proximity to the ammonium group in ax-7-2, constituting a weak hydrogen bond. The relatively small energetic difference between the axial and equatorial conformation in 7 (in gas phase) and its high steric bulk might help to explain the divergent pharmacological profile of some N-benzyl-substituted phenidates that have been shown to display SERT binding ([ 3 H]CIT) comparable to (-)-cocaine. [38] NMR To the best of our knowledge NMR data of the phenidate analogs investigated in this publication have only been published for phenidates 3 and 4. [39, 40] For all compounds the following spectra were recorded: 1 H-NMR, 13 Table 2 , the corresponding spectra can be found in the Supporting Information (Figures S1-13 ). The 1 H NMR spectrum of 3,4dichlorethylphenidate 5 with assignments is depicted in Figure 4 . Furthermore, if an axial position of substituents was predominant, a NOE between the NH proton and piperidine-proton H-2'' should have been observable, which was not the case.
GC-MS
While all compounds had only minor impurities according to NMR-analysis, the GC data obtained with routine drug analysis were not consistent. The chromatograms of 4-methylmethylphenidate 2, ethylphenidate 4 and N-benzyl-ethylphenidate 7 showed only one major compound peak with minor broadening (2: 12.21 min; 4: 11.89 min: 7: 15.79 min) as expected. In contrast, the chromatograms of 3,4-dichloromethylphenidate 3, 3,4-dichloroethylphenidate 5 and ethylnaphthidate 6 showed a strongly broadened major peak naphthyl-ethylacetate, respectively. The compounds resulted from pyrolysis of the molecule under GC-conditions. However, for ethylnaphthidate 6 also the fragment at m/z 84 representing the analyte could be detected in the EI mass spectrum of the following minor peak at 14.96 min alongside the thermal decomposition products. Pyrolysis on column was also observed for 3,4-dichloromethylphenidate 3 and 3,4-dichloroethylphenidate 5. This was consistent with reports related to thermal composition of methylphenidate 1 and compound 3. [41, 42] While the 2-aryl-acetates and 2,3,4,5-tetrahydropyridine detected in the mass spectra of phenidate analogs could also be the products of a McLafferty rearrangement, the peak broadening in the obtained chromatograms seemed to make this unlikely. Peak broadening occurred predominantly for compounds 3, 5 and 6 with higher molecular weight and subsequently higher retention times. These compounds would have been expected to elute at higher final temperatures when using the standard GC-MS protocol. The exception to this was N-benzyl-ethylphenidate 7 which, despite having the highest molecular weight of the investigated compounds, only displayed minor peak broadening. This was possibly due to the benzylic "protection group" at the nitrogen atom (cf. Supporting Information, Figure S 29 ). This was further supported by computational analysis of the thermal decomposition pathways of a simplified model system where two stepwise and two 6-membered concerted reaction pathways were taken into account. The 6-membered transition states reflected the lowest relative energy. Of these, the transition state TS-1 leading to 2,3,4,5-tetrahydropyridine is significantly lower in energy than TS-2 leading to 1,2,3,4-tetrahydropyridine (42.4 kcal mol -1 and 52.0 kcal mol -1 respectively, Figure 8 ). The thermochemistry of the reactions was computed assuming the conversion of the enol-ester to its ester tautomer (dashed line, Figure   8 ). Both reactions are endothermic, but, again, the formation of 2,3,4,5-tetrahydropyridine is slightly less so than 1,2,3,4-tetrahydropyridine (ΔH = 16.4 kcal mol -1 and ΔH = 17.7 kcal mol -1 , respectively). This is in good agreement with the observed higher stability of the relatively bulky N-benzyl-ethylphenidate 7: Since no hydrogen atom is available at the nitrogen atom, the decomposition must follow the pathway leading to the 1,2,3,4tetrahydropyridine product with higher activation barriers and a more stable educt.
To account for these findings, a milder non-standard GC-MS-method was tested for the analysis of 3,4-dichloroethylphenidate 5. With the standard temperature program the ethyl 2- The observed temperature-sensitivity of phenidate analogs might be relevant to forms of consumption of these drugs. For many drugs, vaporizing or smoking is a common route of administration that leads to a very fast onset but shorter duration of effects, thus greatly increasing the addictive potential of these drugs. [43] There seems to be a debate among consumers on internet forums whether phenidates are amenable to vaporization, with some claiming strong effects and others observing none. One such report claims:
"I am aware that most of them are somewhat smokable, such as MPA [methylphenidate], but when I tried vaporizing EPH [ethylphenidate] off of foil it just smelt strongly, and I received no discernible effects from the vapour." [44] This statement corresponds well with the fact that ethyl phenylacetate, originating from thermal decomposition of ethylphenidate, is a known food additive and flavoring agent used in perfumery. Thus, temperature-sensitivity of phenidate-derivatives might have implications for particular routes of administration (e.g. smoking or vaporization) in recreational contexts.
However, a recent investigation into the experiences reported by ethylphenidate users indicated that the most common route of administration was nasal insufflation whereas vaporization, oral and rectal administrations were less common. [44] 
ESI-MS/MS
The fragments observed in ESI-MS 2 for ethylphenidate were in agreement with literature data. [46] Generally, for the phenidate analogs investigated, three distinct product ions with vastly different intensities were observed. The pathways A-C are proposed for the collisioninduced dissociation of phenidate derivatives following ESI (exemplified with ethylphenidate, Figure 10 , Table 3 , for all spectra see Supporting Information, Figures S 40-45 ). Pathway A involves the loss of ethylene (-28 Da) from the protonated molecule via a concerted 6-membered rearrangement. The resulting product ion at m/z 220 exhibited a very low intensity and could only be observed for ethylester derivatives as only these compounds can rearrange via a 6-membered transition state.
Pathway B comprises an intramolecular protonation of the ester moiety followed by subsequent loss of ethanol (-46 Da) and carbon monoxide (-28 Da) yielding an arylium ion m/z 174. This signal displayed a lower intensity for compounds 2 and 3 which can be explained by the lower Lewis basicity of the respective methyl esters. Finally, pathway C involves a loss of ethyl phenylacetate through rearrangement of the molecule through a mechanism similar to the thermal decompositon of phenidates. This would be expected given the facile rearrangement of the non-protonated phenidates upon heating. However a computation of a protonated model systems reveals a barrier that is slightly higher than that for the unprotonated system (TS-3 = 57.1 kcal mol -1 ) and is therefore in agreement with the experiment. The slightly higher barrier also explains the only minor decomposition of phenidate analogs in ESI (drying gas temperature: 180 °C).
IR
IR spectra of all six phenidates 2-7 were obtained for the hydrochloride salts and the neat free base form and are supplied as Supporting Information (Figure S 47-57) with an enlarged fingerprint region and annotation for facile identification. In addition, spectra of the free bases obtained from GC-solid state IR analysis of compounds 3, 4, 5 and 7 are also provided ( Figure S 58-65 ). All spectra were dominated by the C=O absorptions in a narrow range of 1716-1742 for the salts and 1723-1732 cm -1 for the free bases, respectively. A summary of the most distinct bands is given in Table 4 , which can be used for structure confirmation.
Conclusion
The Internet and dark web have been strong drivers for the distribution of psychoactive substances in the last decade, with NPS being marketed at an ever increasing pace. Herein, the structural and spectral properties of six phenidate analogs were determined by employing a combination of X-ray crystallography, NMR spectroscopy, GC-MS, QTOF-MS/MS, IR spectroscopy and DFT computations. These analytical data can be used for future structural elucidation of novel phenidate analogs and provide support to analytical data interpretation.
Thermal decomposition of phenidate analogs under GC-MS standard conditions served as a reminder of the challenges encountered within the field of forensic chemistry. The observed thermal decomposition might also be a phenomenon linked to vaporizing as a form of drug administration (consumption) which might yield similar degradation products.
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